Randomized Trial of a Lifestyle Intervention for Urban Low-Income African Americans with Type 2 Diabetes.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
07 2019
Historique:
received: 26 03 2018
accepted: 22 01 2019
revised: 12 10 2018
pubmed: 10 4 2019
medline: 31 10 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

African Americans suffer more than non-Hispanic whites from type 2 diabetes, but diabetes self-management education (DSME) has been less effective at improving glycemic control for African Americans. Our objective was to determine whether a novel, culturally tailored DSME intervention would result in sustained improvements in glycemic control in low-income African-American patients of public hospital clinics. This randomized controlled trial (n = 211) compared changes in hemoglobin A1c (A1c) at 6, 12, and 18 months between two arms: (1) Lifestyle Improvement through Food and Exercise (LIFE), a culturally tailored, 28-session community-based intervention, focused on diet and physical activity, and (2) a standard of care comparison group receiving two group DSME classes. Cluster-adjusted ANCOVA modeling was used to assess A1c changes from baseline to 6, 12, and 18 months, respectively, between arms. At 6 months, A1c decreased significantly more in the intervention group than the control group (- 0.76 vs - 0.21%, p = 0.03). However, by 12 and 18 months, the difference was no longer significant (12 months - 0.63 intervention vs - 0.45 control, p = 0.52). There was a decrease in A1c over 18 months in both the intervention (β = - 0.026, p = 0.003) and the comparison arm (β = - 0.018, p = 0.048) but no difference in trend (p = 0.472) between arms. The intervention group had greater improvements in nutrition knowledge (11.1 vs 6.0 point change, p = 0.002) and diet quality (4.0 vs - 0.5 point change, p = 0.018) while the comparison group had more participants with improved medication adherence (24% vs 10%, p < 0.05) at 12 months. The LIFE intervention resulted in improved nutrition knowledge and diet quality and the comparison intervention resulted in improved medication adherence. LIFE participants showed greater A1c reduction than standard of care at 6 months but the difference between groups was no longer significant at 12 and 18 months. NCT01901952.

Sections du résumé

BACKGROUND
African Americans suffer more than non-Hispanic whites from type 2 diabetes, but diabetes self-management education (DSME) has been less effective at improving glycemic control for African Americans. Our objective was to determine whether a novel, culturally tailored DSME intervention would result in sustained improvements in glycemic control in low-income African-American patients of public hospital clinics.
RESEARCH DESIGN AND METHODS
This randomized controlled trial (n = 211) compared changes in hemoglobin A1c (A1c) at 6, 12, and 18 months between two arms: (1) Lifestyle Improvement through Food and Exercise (LIFE), a culturally tailored, 28-session community-based intervention, focused on diet and physical activity, and (2) a standard of care comparison group receiving two group DSME classes. Cluster-adjusted ANCOVA modeling was used to assess A1c changes from baseline to 6, 12, and 18 months, respectively, between arms.
RESULTS
At 6 months, A1c decreased significantly more in the intervention group than the control group (- 0.76 vs - 0.21%, p = 0.03). However, by 12 and 18 months, the difference was no longer significant (12 months - 0.63 intervention vs - 0.45 control, p = 0.52). There was a decrease in A1c over 18 months in both the intervention (β = - 0.026, p = 0.003) and the comparison arm (β = - 0.018, p = 0.048) but no difference in trend (p = 0.472) between arms. The intervention group had greater improvements in nutrition knowledge (11.1 vs 6.0 point change, p = 0.002) and diet quality (4.0 vs - 0.5 point change, p = 0.018) while the comparison group had more participants with improved medication adherence (24% vs 10%, p < 0.05) at 12 months.
CONCLUSIONS
The LIFE intervention resulted in improved nutrition knowledge and diet quality and the comparison intervention resulted in improved medication adherence. LIFE participants showed greater A1c reduction than standard of care at 6 months but the difference between groups was no longer significant at 12 and 18 months.
NIH TRIAL REGISTRY NUMBER
NCT01901952.

Identifiants

pubmed: 30963440
doi: 10.1007/s11606-019-04894-y
pii: 10.1007/s11606-019-04894-y
pmc: PMC6614233
doi:

Banques de données

ClinicalTrials.gov
['NCT01901952']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1174-1183

Références

Eval Health Prof. 1998 Mar;21(1):52-65
pubmed: 10183339
Eval Health Prof. 1996 Jun;19(2):208-30
pubmed: 10186911
Eur J Clin Nutr. 1999 Apr;53(4):298-308
pubmed: 10334656
Appetite. 2000 Jun;34(3):269-75
pubmed: 10888290
JAMA. 2001 Jan 10;285(2):182-9
pubmed: 11176811
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Am J Public Health. 2003 Mar;93(3):447-55
pubmed: 12604494
Gerontologist. 2004 Apr;44(2):176-85
pubmed: 15075414
Ann Fam Med. 2005 Nov-Dec;3(6):514-22
pubmed: 16338915
J Clin Hypertens (Greenwich). 2008 May;10(5):348-54
pubmed: 18453793
Am J Manag Care. 2009 Jan;15(1):59-66
pubmed: 19146365
Diabetes Educ. 2009 Mar-Apr;35(2):233-6, 238-41, 244-5
pubmed: 19240246
J Clin Epidemiol. 2011 Mar;64(3):255-7; discussion 258-63
pubmed: 21144706
J Sci Med Sport. 2011 Sep;14(5):411-6
pubmed: 21616714
N Engl J Med. 2011 Oct 20;365(16):1509-19
pubmed: 22010917
Soc Sci Med. 2012 Apr;74(7):1082-90
pubmed: 22373821
J Nutr. 2012 Jun;142(6):1009-18
pubmed: 22513989
J Diabetes Sci Technol. 2012 Mar 01;6(2):380-6
pubmed: 22538150
BMC Health Serv Res. 2012 Jul 23;12:213
pubmed: 22824531
Diabetes Obes Metab. 2014 Jan;16(1):90-3
pubmed: 23911112
J Sci Med Sport. 2014 May;17(3):293-9
pubmed: 23932934
Curr Diab Rep. 2013 Dec;13(6):814-23
pubmed: 24037313
Am J Public Health. 2014 Nov;104(11):2147-55
pubmed: 24228660
Prev Chronic Dis. 2014 May 29;11:E90
pubmed: 24874782
Contemp Clin Trials. 2014 Nov;39(2):246-55
pubmed: 25245954
Diabet Med. 2016 Feb;33(2):169-83
pubmed: 26202820
Ann Intern Med. 2015 Dec 1;163(11):848-60
pubmed: 26414227
Health Aff (Millwood). 2015 Nov;34(11):1916-22
pubmed: 26526250
Circulation. 2015 Dec 8;132(23):2212-9
pubmed: 26644246
Am J Epidemiol. 2016 Apr 1;183(7):622-33
pubmed: 26940115
Diabetes Care. 2016 Nov;39(11):2011-2018
pubmed: 27634391
Diabet Med. 2017 Aug;34(8):1027-1039
pubmed: 28226200
J Health Care Poor Underserved. 2017;28(1):463-486
pubmed: 28239013
Diabetes Educ. 2017 Oct;43(5):449-464
pubmed: 28753378
BMC Health Serv Res. 2018 May 16;18(1):367
pubmed: 29769078
Diabetes Care. 1997 Mar;20(3):299-305
pubmed: 9051376
Diabetes Care. 1997 Apr;20(4):556-61
pubmed: 9096980
Lancet. 1998 Sep 12;352(9131):854-65
pubmed: 9742977

Auteurs

Elizabeth B Lynch (EB)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA. Elizabeth_lynch@rush.edu.

Laurin Mack (L)

Department of Behavioral Sciences, Rush University Medical Center, Chicago, IL, 60625, USA.

Elizabeth Avery (E)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.

Yamin Wang (Y)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.

Rebecca Dawar (R)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.

DeJuran Richardson (D)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.
Department of Mathematics & Computer Science, Lake Forest College, Lake Forest, IL, 60045, USA.

Kathryn Keim (K)

Department of Nutrition, Rush University Medical Center, Chicago, IL, 60625, USA.

Jennifer Ventrelle (J)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.

Bradley M Appelhans (BM)

Department of Preventive Medicine, Rush University Medical Center, 1700 West Van Buren, Suite 470, Chicago, IL, 60625, USA.

Bettina Tahsin (B)

Division of Endocrinology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA.
Division of Endocrinology, Department of Medicine, John H Stroger Hospital, Chicago, IL, USA.

Leon Fogelfeld (L)

Division of Endocrinology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, 60612, USA.
Division of Endocrinology, Department of Medicine, John H Stroger Hospital, Chicago, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH